Tamer Mohamed is the founder of Aspect Biosystems. Aspect Biosystems has raised $50M in total funding. Latest round: Series A. Based in Vancouver, Canada.
Tamer Mohamed is the Founder and CEO of Aspect Biosystems, a biotech company focused on creating bioprinted tissue therapeutics for metabolic indications including pancreatic and liver tissue. He leads a venture-backed company that has secured over $50 million in capital to advance its pipeline toward clinical evaluation.
Full founder directory · Investor directory · Company funding database · Fundraising library